• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1918 年流感大流行的分析能否为想象 2019 年冠状病毒病(COVID-19)的可能规模提供线索?

May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?

机构信息

Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Sergio, Pansini 5, 80131, Naples, Italy.

Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.

出版信息

J Transl Med. 2020 Dec 22;18(1):489. doi: 10.1186/s12967-020-02673-6.

DOI:10.1186/s12967-020-02673-6
PMID:33353549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7753514/
Abstract

BACKGROUND

In 1918 an unknown infectious agent spread around the world infecting over one-third of the general population and killing almost 50 million people. Many countries were at war, the First World War. Since Spain was a neutral country and Spanish press could report about the infection without censorship, this condition is commonly remembered as "Spanish influenza". This review examines several aspects during the 1918 influenza pandemic to bring out evidences which might be useful to imagine the possible magnitude of the present coronavirus disease 2019 (COVID-19).

METHODS

In the first part of this review we will examine the origin of the SARS-Coronavirus-2 and 1918 Spanish Influenza Virus and the role played by host and environment in its diffusion. We will also include in our analysis an evaluation of different approaches utilized to restrain the spread of pandemic and to treat infected patients. In the second part, we will try to imagine the magnitude of the present COVID-19 pandemic and the possible measures able to restrain in the present environment its spread.

RESULTS

Several factors characterize the outcome in a viral pandemic infection. They include the complete knowledge of the virus, the complete knowledge of the host and of the environment where the host lives and the pandemic develops.

CONCLUSION

By comparing the situation seen in 1918 with the current one, we are now in a more favourable position. The experience of the past teaches us that their success is linked to a rapid, constant and lasting application. Then, rather than coercion, awareness of the need to observe such prevention measures works better.

摘要

背景

1918 年,一种未知的传染病原体在全球范围内传播,感染了超过三分之一的人口,导致近 5000 万人死亡。当时许多国家都卷入了第一次世界大战。由于西班牙是中立国,西班牙媒体可以不受审查地报道疫情,因此这种情况通常被称为“西班牙流感”。本综述探讨了 1918 年流感大流行期间的几个方面,以揭示可能有助于想象当前 2019 年冠状病毒病(COVID-19)大流行规模的证据。

方法

在本综述的第一部分,我们将检查 SARS-CoVoronavirus-2 和 1918 年西班牙流感病毒的起源,以及宿主和环境在其传播中的作用。我们还将在分析中包括对用于抑制大流行传播和治疗感染患者的不同方法的评估。在第二部分,我们将尝试想象当前 COVID-19 大流行的规模以及在当前环境下可能采取的措施来限制其传播。

结果

几个因素决定了病毒性大流行感染的结果。其中包括对病毒的完全了解、对宿主的完全了解以及宿主生活和大流行发展的环境的了解。

结论

通过将 1918 年的情况与当前情况进行比较,我们现在处于更有利的地位。过去的经验告诉我们,成功取决于快速、持续和持久的应用。那么,与其强制要求,不如让人们意识到需要遵守这些预防措施,这样效果会更好。

相似文献

1
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?1918 年流感大流行的分析能否为想象 2019 年冠状病毒病(COVID-19)的可能规模提供线索?
J Transl Med. 2020 Dec 22;18(1):489. doi: 10.1186/s12967-020-02673-6.
2
Lessons to be learnt from 100 year old 1918 influenza pandemic viz a viz 2019 corona pandemic with an eye on NTEP.从1918年流感大流行(距今已有100年)中吸取的经验教训与2019年新冠大流行相关,并着眼于国家结核病消除计划(NTEP)。
Indian J Tuberc. 2020 Dec;67(4S):S132-S138. doi: 10.1016/j.ijtb.2020.09.032. Epub 2020 Oct 8.
3
Will prenatal exposure to SARS-CoV-2 define a birth cohort with accelerated aging in the century ahead?产前暴露于 SARS-CoV-2 是否会定义未来一个世纪加速衰老的出生队列?
J Dev Orig Health Dis. 2021 Oct;12(5):683-687. doi: 10.1017/S204017442000104X. Epub 2020 Nov 10.
4
[A new Spanish enemy; the Spanish flu in the Netherlands in the period 1918-1920].[一个新的西班牙敌人;1918 - 1920年期间西班牙流感在荷兰]
Ned Tijdschr Geneeskd. 2020 Aug 13;164:D5224.
5
Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy.意大利西班牙流感与2019年冠状病毒病死亡率的历史比较。
J Infect Dis. 2024 Jun 14;229(6):1928-1929. doi: 10.1093/infdis/jiae115.
6
Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.通过基于细胞的再生医学抗击 COVID-19 之战:从 1918 年西班牙流感和其他先前的大流行中吸取的教训。
Stem Cell Rev Rep. 2021 Feb;17(1):9-32. doi: 10.1007/s12015-020-10026-5.
7
Understanding dynamics of pandemics.理解大流行病的动态。
Turk J Med Sci. 2020 Apr 21;50(SI-1):515-519. doi: 10.3906/sag-2004-133.
8
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
9
Estimating transportation role in pandemic diffusion in Nigeria: A consideration of 1918-19 influenza and COVID-19 pandemics.估算尼日利亚大流行扩散中的交通作用:考虑 1918-19 年流感和 COVID-19 大流行。
J Glob Health. 2020 Dec;10(2):020501. doi: 10.7189/jogh.10.020501.
10
The beginning and ending of a respiratory viral pandemic-lessons from the Spanish flu.呼吸道病毒大流行的始末——以西班牙流感为例。
Microb Biotechnol. 2022 May;15(5):1301-1317. doi: 10.1111/1751-7915.14053. Epub 2022 Mar 22.

引用本文的文献

1
Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with "Spanish Flu"?与“西班牙流感”相比,诊断方法、治疗手段和疫苗对新冠疫情演变产生了影响吗?
Pathogens. 2023 Jun 23;12(7):868. doi: 10.3390/pathogens12070868.
2
Household secondary attack rate in SARS-CoV-2 infection during the second wave of the COVID-19 pandemic in South India.印度南部新冠疫情第二波期间SARS-CoV-2感染的家庭二代发病率。
J Family Med Prim Care. 2022 Oct;11(10):6268-6273. doi: 10.4103/jfmpc.jfmpc_452_22. Epub 2022 Oct 31.
3
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting.从西班牙流感到 COVID-19 的一个世纪呼吸道传染病的叙述性回顾,以及纳米技术对 COVID-19 诊断和免疫系统增强的影响。
Virol J. 2022 Oct 24;19(1):167. doi: 10.1186/s12985-022-01902-2.
4
SARS-CoV-2 and COVID-19: A Narrative Review.SARS-CoV-2 和 COVID-19:一个叙事性回顾。
Br J Biomed Sci. 2022 Sep 6;79:10426. doi: 10.3389/bjbs.2022.10426. eCollection 2022.
5
Effect Evaluation of Echocardiography on Right Ventricular Function in Patients after the Recovering from Coronavirus Disease 2019.超声心动图对新冠肺炎患者右心功能恢复的效果评价。
Comput Math Methods Med. 2022 Jul 14;2022:6161015. doi: 10.1155/2022/6161015. eCollection 2022.
6
The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic.细胞因子风暴通路在病毒性呼吸道大流行临床过程中的潜在作用
Biomedicines. 2021 Nov 15;9(11):1688. doi: 10.3390/biomedicines9111688.
7
The Pandemic Year 2020: World Map of Coronavirus Research.《2020 年大流行之年:冠状病毒研究世界地图》
J Med Internet Res. 2021 Sep 8;23(9):e30692. doi: 10.2196/30692.
8
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.COVID-19 在自身免疫性炎症性关节病和自身炎症性疾病中的发病机制、发病率和结局。
Adv Rheumatol. 2021 Jul 8;61(1):45. doi: 10.1186/s42358-021-00204-5.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Harms of public health interventions against covid-19 must not be ignored.针对新冠疫情的公共卫生干预措施的危害绝不能被忽视。
BMJ. 2020 Nov 2;371:m4074. doi: 10.1136/bmj.m4074.
3
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.酵母表达的 SARS-CoV 重组受体结合域(RBD219-N1)与氢氧化铝配制而成,可诱导保护性免疫,并降低免疫增强作用。
Vaccine. 2020 Nov 3;38(47):7533-7541. doi: 10.1016/j.vaccine.2020.09.061. Epub 2020 Sep 22.
4
Vaccines for COVID-19.COVID-19 疫苗。
Clin Exp Immunol. 2020 Nov;202(2):162-192. doi: 10.1111/cei.13517. Epub 2020 Oct 18.
5
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.托珠单抗治疗重症新型冠状病毒肺炎患者:一项回顾性队列研究
Lancet Rheumatol. 2020 Aug;2(8):e474-e484. doi: 10.1016/S2665-9913(20)30173-9. Epub 2020 Jun 24.
6
COVID-19 Vaccine: A comprehensive status report.新型冠状病毒肺炎疫苗:全面现状报告。
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
7
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.意大利某单一机构中 COVID-19 患者接受白细胞介素 6(IL-6)受体拮抗剂沙利鲁单抗治疗的结果和生物标志物分析。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-001089.
8
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.COVID-19 病患者死亡率:主要组织相容性复合体 (MHC) 与严重急性呼吸综合征 2 (SARS-CoV-2) 变体的关联。
Int J Infect Dis. 2020 Sep;98:454-459. doi: 10.1016/j.ijid.2020.07.016. Epub 2020 Jul 18.
9
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
10
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.构建并免疫研究一种 SARS-CoV-2 刺突蛋白的 mFc 融合受体结合域(RBD)作为针对 SARS-CoV-2 感染的亚单位疫苗。
Chem Commun (Camb). 2020 Aug 7;56(61):8683-8686. doi: 10.1039/d0cc03263h. Epub 2020 Jul 2.